[1]
G. Nadeau, “Double anticholinergic therapy for refractory neurogenic and non-neurogenic detrusor overactivity in children: Long-term results of a prospective open-label study”, CUAJ, vol. 8, no. 5-6, pp. 175–80, Jun. 2014.